HIGHLIGHTS
- What: The aim of this study is to deeply characterize patients with MASLD, by mean of pre-clinical, clinical, genetics and metabolomics study in respect to their clinical risk of CVD, in the most non-invasive way possible, to offer an insight into patient management in daily clinical practice.
- Who: Mario Masarone from the Department of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Baronissi, SA, Italy have published the Article: Evaluating cardiovascular risk in metabolic steatosis with precision medicine non-invasive approaches: insights from a cohort study, in the Journal: (JOURNAL)
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.